Beckman Coulter Integration Progressing at Danaher, Refiling Troponin Test with FDA While MDx R&D Continues | GenomeWeb

By Tony Fong

SAN FRANCISCO (GenomeWeb News) — As Danaher proceeds with the integration of Beckman Coulter, there is "a lot of work still to do in quality and innovation," but progress has been made, Danaher CEO Larry Culp said at the JP Morgan Healthcare Conference here today.

And while the Beckman Coulter business may not improve substantially over a flattish 2011, momentum can be built this coming year into 2013, Culp said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.